People channel feed

For­mer Gale­na chief Mark Ahn back in hot wa­ter as DOJ lev­els in­sid­er trad­ing charges for con­sul­tant work

5 years ago
Pharma

Ex-Bio­gen CEO Jim Mullen steps back to the helm of a biotech, and once again he has a crit­i­cal chal­lenge to con­front

5 years ago

'Can't say no': Kite Phar­ma taps Frank Neu­mann as new head of clin­i­cal de­vel­op­ment

5 years ago

'Gene ther­a­py is at an in­flec­tion point': Kathy High on her new perch at AskBio and the field­'s fu­ture

5 years ago

Mer­ck CEO Ken Fra­zier pre­pares to step down af­ter 29 years, hand­ing the keys to the Keytru­da race car to CFO Robert Davis

5 years ago

Mads Krogs­gaard Thom­sen hands off CSO job at No­vo Nordisk af­ter a 30-year run, then piv­ots to CEO post at huge No­vo Foun­da­tion

5 years ago

Biotech scan­dal drags on as the feds on­ly score par­tial vic­to­ry against ex­ecs charged with cook­ing the books

5 years ago

Eli Lil­ly's new can­cer R&D chief has some things to say about drug dis­cov­ery, the dif­fi­cul­ty in find­ing new drugs to buy and the Venn dilem­ma

5 years ago
R&D

Ex­clu­sive: Third Rock­'s stealthy MO­MA Ther­a­peu­tics taps a long­time Mil­len­ni­um, Take­da vet as CEO

5 years ago

Josh Bilenker ends his brief role in an un­usu­al ex­per­i­ment at Eli Lil­ly, bow­ing out as head of their Loxo can­cer R&D unit

5 years ago

Bay­er and AskBio ex­pand grand gene ther­a­py am­bi­tions with new Parkin­son's pro­gram, top sci­en­tist

5 years ago
Cell/Gene Tx

Ad­vo­ca­cy groups don't want Janet Wood­cock to head the FDA, blast­ing ‘reg­u­la­to­ry fail­ures’ in opi­oid cri­sis

5 years ago
FDA+

Vivek Ra­maswamy and Matt Gline pen share­hold­er let­ters about the changes now un­der­way at Roivant

5 years ago

Yale can­cer spe­cial­ist Char­lie Fuchs tapped as new glob­al de­vel­op­ment chief for Roche/Genen­tech

5 years ago

De­val Patrick joins Cerev­el board, fur­ther in­ter­twin­ing com­pa­ny with Bain Cap­i­tal

5 years ago

End­points poll: Janet Wood­cock takes the (in­ter­im) helm at the FDA. And a large ma­jor­i­ty of our read­ers want her to stay there

5 years ago
FDA+

As he wraps stormy FDA tenure, Hahn ad­mits 'there was a sub­stan­tial amount of pres­sure' from White House — re­port

5 years ago

Gilead­'s Kite re­cruits an Ab­b­Vie/NIH vet­er­an to head up cell ther­a­py R&D. And he's tak­ing aim at AML in a fe­ro­cious­ly com­pet­i­tive field

5 years ago

Biden el­e­vates White House sci­ence of­fice to Cab­i­net-lev­el, with ge­neti­cist Er­ic Lan­der put for­ward to lead pol­i­cy

5 years ago

Janet Wood­cock is in the run­ning for FDA com­mis­sion­er — what does that mean for the agen­cy's fu­ture?

5 years ago
FDA+

Bris­tol My­er­s' top hema­tol­ogy ex­ec is on his way out — right on the heels of a $6B CVR im­plo­sion

5 years ago

R&D ex­ec faces up to 10 years in prison on charges he stole “thou­sands” of top se­cret re­search doc­u­ments from Mer­ck

5 years ago
R&D

Janet Wood­cock to be act­ing FDA com­mis­sion­er while Biden team fi­nal­izes nom­i­nee — re­ports

5 years ago
FDA+

Mark Cuban jumps out of the Shark Tank and in­to gener­ic phar­ma with a plan to of­fer dirt-cheap drugs

5 years ago
First page Previous page 61626364656667 Next page Last page
A service from the Financial Times